STOCK TITAN
  1. Home
  2. Sec-filings
  3. MEDP
  4. [Form 4] Medpace Holdings, Inc. Insider Trading Activity

Medpace (NASDAQ: MEDP) director converts 36 RSUs, now holds 32,789 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Medpace Holdings director Brian T. Carley exercised restricted stock units into common stock. On March 31, 2026, 36 restricted stock units converted into 36 shares at a stated price of $0.00 per share, bringing his direct common stock holdings to 32,789 shares and leaving 107 restricted stock units outstanding from a prior grant.

Positive

  • None.

Negative

  • None.
Insider Carley Brian T
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Unit 36 $0.00 --
Exercise Common Stock 36 $0.00 --
Holdings After Transaction: Restricted Stock Unit — 107 shares (Direct); Common Stock — 32,789 shares (Direct)
Footnotes (1)
  1. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. On November 28, 2025, the Reporting Person was granted 143 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.
RSUs exercised 36 units Converted into 36 Medpace common shares on March 31, 2026
Common shares held after transaction 32,789 shares Direct Medpace common stock ownership following March 31, 2026 conversion
Remaining RSUs 107 units Restricted stock units held after 36 units vested and converted
Original RSU grant 143 units Granted on November 28, 2025, vesting in four installments
Exercise price per share $0.00/share Stated price for the 36 Medpace common shares delivered
Restricted Stock Unit financial
"Each restricted stock unit represents a contingent right to receive one share of MEDP common stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
contingent right financial
"represents a contingent right to receive one share of MEDP common stock"
vesting financial
"restricted stock units vesting in four approximately equal installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Carley Brian T
(Last)(First)(Middle)
C/O MEDPACE HOLDINGS, INC.
5375 MEDPACE WAY
(Street)
CINCINNATI OHIO 45227
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/31/2026M36A(1)32,789D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)03/31/2026M36 (2) (2)Common Stock36$0107D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
2. On November 28, 2025, the Reporting Person was granted 143 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.
Remarks:
/s/ Stephen P. Ewald, Attorney-in-Fact for Brian T. Carley04/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Medpace (MEDP) director Brian T. Carley report?

Brian T. Carley reported exercising restricted stock units into common shares. On March 31, 2026, 36 restricted stock units converted into 36 Medpace common shares, increasing his direct stock ownership while reducing his restricted unit balance from an earlier equity grant.

How many Medpace (MEDP) shares does Brian T. Carley hold after this Form 4?

After the March 31, 2026 transaction, Brian T. Carley directly holds 32,789 Medpace common shares. This reflects the addition of 36 shares from the restricted stock unit conversion, as disclosed in the Form 4 insider trading report filed for Medpace Holdings.

What restricted stock unit grant underlies Brian T. Carley’s Medpace (MEDP) Form 4?

The Form 4 references a grant of 143 restricted stock units made on November 28, 2025. These units vest in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026, each delivering one Medpace common share per unit.

How many Medpace (MEDP) restricted stock units remain for Brian T. Carley?

Following the March 31, 2026 vesting and conversion of 36 restricted stock units, Brian T. Carley holds 107 restricted stock units. Each unit represents a contingent right to receive one Medpace common share as future vesting installments occur under the original 143-unit grant.

Was Brian T. Carley’s Medpace (MEDP) transaction a market purchase or sale?

The transaction was an exercise and conversion of restricted stock units, not an open-market trade. Code M on the Form 4 indicates derivative exercise, with 36 units converting into 36 Medpace common shares at a stated price of $0.00 per share.